Results 121 to 130 of about 50,558 (217)

Ergotismo inducido por Ritonavir [PDF]

open access: yes, 2019
Quisiera hacer algunos comentarios sobre el reporte de caso ‘Ergotismo inducido por ritonavir’ publicado en el número ...
Valdivia-Infantas, Melinda M.
core  

Pharmacokinetics of Once-Daily Darunavir-Ritonavir and Atazanavir-Ritonavir over 72 Hours following Drug Cessation

open access: yes, 2011
The object of this study was to investigate the pharmacokinetics of darunavir-ritonavir and atazanavir-ritonavir once-daily dosing over 72 h (h) following drug intake cessation.
Natalia Seymour   +8 more
core   +1 more source

Model‐Based Tacrolimus Dosing Using the Population Pharmacokinetic Analysis Under the Nirmatrelvir/Ritonavir Therapy

open access: yesCPT: Pharmacometrics & Systems Pharmacology
Nirmatrelvir/ritonavir is an antiviral agent used against severe acute respiratory syndrome coronavirus 2 infection and inhibits cytochrome P450 3A and P‐glycoprotein.
Kotaro Itohara   +14 more
doaj   +1 more source

The Impact of the Core-Shell Fiber Composition on the Properties and Stability of the Electrospun Films

open access: yesNanotechnology, Science and Applications
Ewelina Łyszczarz,1 Aleksandra Rezka,1 Dorota Majda,2 Witold Jamróz,1 Aleksander Mendyk1 1Chair of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Jagiellonian University Medical College, Cracow, Lesser Poland Voivodeship,
Łyszczarz E   +4 more
doaj  

Patent Landscape Report on Ritonavir Dataset.

open access: yes
This report is dedicated to Ritonavir - an antiretroviral drug used to treat HIV infection and AIDS. A major goal of the report is to highlight the technology timeline for Ritonavir from the first filing of this compound to the present filings.

core   +1 more source

Potential Drug-Drug Interactions With Nirmatrelvir/Ritonavir Among Long-Term Care Facility Residents. [PDF]

open access: yesJ Am Med Dir Assoc
Khan MA   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy